All Pfizer articles – Page 5

Opinion
To merge or not to merge

2014-06-01T00:00:00Z

The big questions remain unanswered
Opinion
Messy megamergers

2014-05-29T00:00:00Z

Big company buyouts are more about immediate gains and rarely consider the impact on research, says Derek Lowe
Business
Time called on Pfizer–AstraZeneca deal

2014-05-28T00:00:00Z

Pfizer could make a fresh approach after six months under City takeover rules
Business
AstraZeneca refuses Pfizer’s ‘final’ offer

2014-05-19T00:00:00Z

Pfizer pledges not to make hostile bid direct to shareholders
Business
Pfizer presses hard for AstraZeneca deal

2014-05-14T00:00:00Z

Executives face down international controversy over tax schemes and previous post-merger record
Business
Pfizer courts AstraZeneca megamerger

2014-04-29T00:00:00Z

AZ rebuffs public dealmongering
Business
Generics triumph in anti-inflammatory patent battle

2014-04-25T00:00:00Z

Pfizer settles deals to allow copycat celecoxib
Business
Weathering the storm

2014-01-06T00:00:00Z

Pharmaceutical industry roundup 2013
Business
Pfizer teams up with GSK in cancer drug trial

2013-11-25T00:00:00Z

Two companies will collaborate to develop a combination therapy for melanoma
Business
Counterfeit anxiety pills seized in Switzerland

2013-10-21T00:00:00Z

1 million fake tablets were en route from China to Egypt
Business
Pfizer reshuffle hints at future split decision

2013-07-31T00:00:00Z

Could pharma giant’s ‘value’ and ‘innovative’ segments get broken apart?
Business
Ups and downs for erectile dysfunction drugs

2013-06-27T00:00:00Z

First new drug in a decade approved in Europe as Viagra patent expires
Business
Pfizer and Takeda win $2.15bn in patent payout

2013-06-14T00:00:00Z

Teva and Sun fined for selling generics before patent expiry
Business
Buy Viagra online - direct from the manufacturer

2013-05-07T00:00:00Z

Pfizer launches website for mail order erectile dysfunction drug prescriptions
Business
Zoetis IPO launches at $2.2bn

2013-02-01T00:00:00Z

Pfizer spin off will be a big player among a relatively small number of public companies focusing on animal heatlh
Business
Pfizer's lost gold

2012-12-10T00:00:00Z

A stash of gold dust bought for $700,000 last year has gone missing from a Pfizer lab in St Louis, Missouri, US
Business
Pfizer to pay $700m for Ritalin re-formulated

2012-10-22T00:00:00Z

Pfizer to buy a company with a liquid formulation of historic ADHD drug methylphenidate
Business
Pfizer to pay $250m for Nexium

2012-08-17T00:00:00Z

AstraZeneca has sold rights to an over the counter version of its heartburn tablets
Business
Elan spins off drug discovery

2012-08-14T00:00:00Z

The new company will be called Neotope Biosciences and focus on chronic degenerative diseases
Business
Bapineuzunab dropped

2012-08-09T00:00:00Z

Development for the Alzheimer’s treatment stopped after clinical tests